Jeong-soo Jang

Title: The Innovative Mind of Jeong-soo Jang: A Pioneer in Cardiovascular Therapeutics

Introduction: Jeong-soo Jang is an accomplished inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of cardiovascular treatments. With one patent to his name, Jeong-soo Jang embodies the spirit of innovation that drives advancements in healthcare.

Latest Patents: Jeong-soo Jang's most notable patent is for "Amlodipine gentisate and a method of its preparation." This invention pertains to the development of an acid salt of amlodipine gentisate, specifically a crystalline acid salt produced by reacting amlodipine with gentisic acid. The resulting compound is advantageous for treating cardiovascular diseases due to its low toxicity, excellent stability, improved pharmaceutical efficacy, and sustained blood concentration.

Career Highlights: Currently, Jeong-soo Jang is employed at SK Chemicals Co., Ltd., where he focuses on developing innovative pharmaceuticals. His work emphasizes not only the efficacy of therapeutic compounds but also their safety for patient use, a crucial aspect in the medical industry.

Collaborations: Throughout his career, Jeong-soo Jang has worked alongside talented colleagues, including Jae-Sun Kim and Jin Young Choi. Their collaborations in research and development have further fueled advancements in their projects, enhancing the quality and effectiveness of new pharmaceutical solutions.

Conclusion: Jeong-soo Jang stands as a testament to the vital role that inventors play in the medical field. His innovative approach to drug formulation and commitment to improving healthcare outcomes highlight the importance of research and development in addressing critical health issues. As he continues his work at SK Chemicals Co., Ltd., the future holds promise for further innovations that may transform cardiovascular treatment.